Understanding Hair Loss in Men and Women: Causes, Statistics, and Treatments

Androgenetic alopecia, known as male or female pattern baldness, affects up to 80 percent of men and 50 percent of women by age 70, according to data provided by the American Hair Loss Association. This condition remains the most common form of hair loss for both genders, though the timing of onset and physical patterns of thinning differ significantly between men and women.

Dr. Neal Shah, a dermatologist at Stony Brook Medicine in New York, reports a recent trend of women seeking medical treatment for hair loss earlier than in the past. He notes that many women historically attempted to resolve the issue using hair products or altering their hairstyles before consulting a physician.

Differences in Hair Loss Patterns and Timing

Male pattern baldness frequently begins in early adulthood. According to the provided statistics, 1 in 4 men experience hair loss before age 21, and approximately 2 in 3 men have begun losing hair by age 35.

Women generally experience hair loss later in life. One study indicated that most consultations for female hair loss occur between the ages of 30 and 59. This timing is often linked to hormonal shifts during pregnancy and menopause, which can trigger shedding and alter growth cycles.

The visual distribution of the loss also differs. Men typically develop a receding hairline or bald spots at the crown and temples. Women generally experience diffuse thinning across the top of the scalp, while the frontal hairline usually remains intact.

Biological Causes of Androgenetic Alopecia

In men, the hormone dihydrotestosterone (DHT) is the primary driver of pattern baldness. DHT shrinks hair follicles over time, leading to thinning and recession. While genetics play a role, some experts suggest other unknown factors contribute, challenging the traditional belief that the trait is inherited solely from the maternal grandfather.

Women also face testosterone-induced hair loss, particularly during perimenopause and postmenopause. Dr. Shah explains that these women experience a shift toward testosterone-induced loss, though the distribution differs from the male pattern.

Other Medical Triggers for Hair Loss

Beyond genetic pattern baldness, various medical conditions and external factors can cause shedding. For men, hair loss can be a side effect of medications used to treat heart disease, depression, arthritis, or cancer. Scalp infections, such as ringworm, and high stress levels are also cited as causes.

Women may experience hair loss due to a wider range of systemic and autoimmune conditions, including:

• Telogen effluvium: A type of shedding triggered by stress, which is more common in women.
• Polycystic metabolic ovarian syndrome (PMOS): A condition where high levels of androgen hormones contribute to hair loss.
• Alopecia areata: An autoimmune disease that attacks hair follicles, causing patchy loss.
• Thyroid disorders: Both hypothyroidism and hyperthyroidism can disrupt the growth cycle, causing follicles to exit the growth phase prematurely.
• Traction alopecia: Hair loss caused by tight hairstyles that pull on the root.
• Nutritional deficiencies: Specifically iron deficiency.
• Medical treatments: Chemotherapy and radiation that damage follicle cells.

FDA-Approved and Off-Label Treatments

Early intervention is critical for successful treatment. Dr. Shah emphasizes that the primary goal is treating the underlying cause of the specific hair loss issue.

Several medications are used to manage the condition:

• Minoxidil (Rogaine): An FDA-approved topical medication available over the counter for both men and women.
• Finasteride (Propecia): An FDA-approved prescription medication for male pattern baldness, available as an oral tablet or topical spray.
• Corticosteroids: Used to reduce inflammation and treat sudden, extensive loss; these are administered via injection, oral tablets, or topical application.

Dr. Shah notes that other medications may be used off-label as secondary treatments, including dutasteride, spironolactone, doxycycline, ketoconazole, and low-dose oral minoxidil. He cautions that these options come with specific risks and side effects that must be tailored to the individual patient.

Clinical Regrowth Procedures

When medications are insufficient, healthcare providers may offer in-office procedures to stimulate growth or restore thinning areas.

Hair transplants involve moving hair from one part of the body to the scalp. Other options include light therapy, which uses medical-grade lights on the scalp, and Platelet-Rich Plasma (PRP) therapy. In PRP therapy, a provider concentrates platelets from a patient’s own blood and injects them into the scalp to stimulate growth.